The goal of the present study was to improve our understanding of the molecular mechanisms that are impaired in PD, and to verify the potential neuroprotective effects of an increased level of alpha-synuclein acetylation by the inhibition of HDAC6. Here, SNCA is linked to Parkinson disease.